BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10805158)

  • 21. Structural features of ribonucleotide reductase.
    Nikas I; McLauchlan J; Davison AJ; Taylor WR; Clements JB
    Proteins; 1986 Dec; 1(4):376-84. PubMed ID: 2835765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single amino acid substitution in the large subunit of herpes simplex virus type 1 ribonucleotide reductase which prevents subunit association.
    Nikas I; Darling AJ; Lankinen HM; Cross AM; Marsden HS; Clements JB
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2369-76. PubMed ID: 2172449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
    Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ; Fong Y
    J Virol; 2001 Aug; 75(15):7050-8. PubMed ID: 11435585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine.
    Fennewald SM; Mustain S; Ojwang J; Rando RF
    Antiviral Res; 1995 Jan; 26(1):37-54. PubMed ID: 7741520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
    Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
    Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of immediate early protein ICP27/IE63 and thymidine kinase in the course of reactivation of latent herpes simplex virus 1 infection.
    Durmanová V; Rajcáni J
    Acta Virol; 2003; 47(3):159-65. PubMed ID: 14658844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of the antigenic sites and intrinsic protein kinase domain within a 300 amino acid segment of the ribonucleotide reductase large subunit from herpes simplex virus type 2.
    Ali MA; Prakash SS; Jariwalla RJ
    Virology; 1992 Mar; 187(1):360-7. PubMed ID: 1371028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions.
    Mulvey M; Arias C; Mohr I
    J Virol; 2006 Aug; 80(15):7354-63. PubMed ID: 16840316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequences of the ribonucleotide reductase-encoding genes of equine herpesvirus 4.
    Riggio MP; Onions DE
    Gene; 1994 Jun; 143(2):217-22. PubMed ID: 8206376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.
    Smith CC; Aurelian L
    Virology; 1997 Aug; 234(2):235-42. PubMed ID: 9268154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector.
    Lamarche N; Massie B; Richer M; Paradis H; Langelier Y
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1785-92. PubMed ID: 2167932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
    Fu X; Tao L; Cai R; Prigge J; Zhang X
    Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates.
    Kean JM; Kipp SA; Miller PS; Kulka M; Aurelian L
    Biochemistry; 1995 Nov; 34(45):14617-20. PubMed ID: 7578069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.
    Smith CC; Yu YX; Kulka M; Aurelian L
    J Biol Chem; 2000 Aug; 275(33):25690-9. PubMed ID: 10833516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution of herpes simplex virus type 1 ribonucleotide reductase activity from the large and small subunits.
    Darling AJ; McKay EM; Ingemarson R; Preston VG
    Virus Genes; 1989 Mar; 2(2):187-94. PubMed ID: 2541563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation.
    Smith CC; Luo JH; Hunter JC; Ordonez JV; Aurelian L
    Virology; 1994 May; 200(2):598-612. PubMed ID: 8178446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
    J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL.
    Telford E; Lankinen H; Marsden H
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1373-8. PubMed ID: 2161904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.